734-936-8000 - Service Desk | Request Support

Conducting Clinical Trials During a Pandemic COVID-19 - A View From Our Study Teams

To begin this activity, click Enroll. Once logged in, learners can access educational content, assessments, and evaluations. Learners who successfully complete the activity will be able to print a certificate.

Step Status
Educational Materials
Release Date: Sat, 1/1/22
Termination Date: Thu, 11/30/23
Credits: 1.25
Educational Objectives: At the end of this activity, participant should be able to:

Teach faculty and staff proper methods to conduct an FDA or ICH regulated trial or study from inception to conclusion.

Target Audience: This activity is appropriate for Administrators, Nurses, Other Healthcare Professionals, Physicians in the fields of Adolescent Medicine, Anesthesiology, Cardiac Surgery, Cardiovascular Medicine, Critical Care Medicine, Dermatology, Emergency Medicine, Endocrinology, Family Medicine, Gastroenterology, General Medicine, Geriatric Medicine, Hematology/Oncology, Hepatology, Immunology, Infectious Disease, Internal Medicine, Medical Oncology, Nephrology, Neurology, Neurosurgery, Obstetrics & Gynecology, Ophthalmology, Orthopaedic Surgery, Other Healthcare Professions, Otolaryngology, Palliative Medicine, Pathology, Pediatric Surgery, Pediatrics, Physical Medicine & Rehabilitation, Primary Care, Psychiatry, Psychology, Pulmonology, Radiation Oncology, Radiology, Rheumatology, Sleep Medicine, Social Work, Sports Medicine, Surgery, Transplant Surgery, Trauma Surgery, Urology, Vascular Surgery.
Accreditation and Credit Designation:

The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Michigan Medical School designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Original Release Date: November 2020
Termination Date: November 2023

Additional Info: Bibliographic Resources
  1. Clin Infect Dis. 2020 May 11;ciaa560. doi: 10.1093/cid/ciaa560
  2. Am J RespirCritCare Med. 2020 May 1. doi: 10.1164/rccm.202001-0003LEs
  3. COVID-19 and blood type https://doi.org/10.1101/2020.09.04.20188318
  4. Phase 1 / 2 data https://doi.org/10.1016/S0140-6736(20)31604-4
  5. Remdesivir Trials https://jamanetwork.com/journals/jama/fullarticle/2769870

Credits available:

AMA PRA Category 1: 1.25
Participation: 1.25